However, during the process of differentiation, the CDKN2 gene undergoes a series of epigenetic changes in response to BCR-ABL-induced oncogenic signals and consequently stimulates p53 which degrades initial tumor cells via apoptosis. Here, CDKN2A is linked to neoplasm.